Although the independence of synergism from EGFR increased the possibility of this result, it was still surprising since EGFR inhibitors inhibit several other RTKs in cancer cells [41], which would reprogram intracellular machinery, leading to distinctive dependency signatures. The gene discussed is EGFR; the disease is cancer.